Entering text into the input field will update the search result below

COVID-19 test demand drives Luminex Q2 sales growth

Aug. 04, 2020 4:11 PM ETLuminex Corporation (LMNX) StockLMNXBy: Douglas W. House, SA News Editor5 Comments
  • Luminex (NASDAQ:LMNX) Q2 results:
  • Total revenue: $109.5M (+31.8%); Assays: $61.2M (+94.9%). Sales growth driven by demand for pandemic-related tests.
  • Net income: $12.5M (+355.1%); EPS: $0.27 (+345.5%).
  • Cash flow ops: $31.3M (+430.5%).
  • Q3 guidance: Revenue: at least $100M (+26%). Consensus: $107M.
  • 2020 guidance: Revenue: at least $415M (+24%). Consensus: $387M.
  • Shares up 3% after hours.
  • Luminex EPS beats by $0.17, beats on revenue

Recommended For You

Related Stocks

SymbolLast Price% Chg
LMNX--
Luminex Corporation